300 million child-friendly antimalarial treatments supplied without profit by Novartis
Novartis announced today that it has reached a delivery milestone of 300 million paediatric antimalarial…
Browsing: First WHO prequalified child-friendly ACT
Novartis announced today that it has reached a delivery milestone of 300 million paediatric antimalarial…